Related Experiment Video
Updated: Oct 18, 2025

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
Published on: December 10, 2016
Cefiderocol, a new antibiotic against multidrug-resistant Gram-negative bacteria
1Francisco López Medrano. Unit of Infectious Diseases. Hospital Universitario "12 de Octubre". Madrid, Spain. flmedrano@yahoo.es.
Cefiderocol, an antibiotic for Gram-negative bacterial infections, shows promise but requires further study. A clinical trial noted higher mortality in patients receiving cefiderocol, particularly those with severe Acinetobacter infections.
Area of Science:
- Infectious Diseases
- Pharmacology
- Microbiology
Background:
- Cefiderocol is a novel siderophore cephalosporin targeting Gram-negative bacteria (GNB).
- It utilizes bacterial iron uptake pathways to penetrate GNB and overcome resistance mechanisms.
Purpose of the Study:
- To review the efficacy and safety of cefiderocol based on clinical trial data.
- To assess cefiderocol's role in treating complicated urinary tract infections (cUTI), hospital-acquired bacterial pneumonia (HABP), and ventilator-associated bacterial pneumonia (VABP).
Main Methods:
- Analysis of clinical data from APEKS-cUTI, APEKS-NP, and CREDIBLE-CR trials.
- Evaluation of cefiderocol's performance in adult patients with limited treatment options.
Main Results:
- Cefiderocol demonstrated efficacy in treating specific GNB infections.
- The CREDIBLE-CR trial indicated a higher all-cause mortality in the cefiderocol group, especially in severe Acinetobacter spp. infections.
Conclusions:
- Cefiderocol is approved for specific GNB infections in adults with limited options.
- Further Phase III clinical studies are essential to fully evaluate cefiderocol's efficacy and safety in treating severe infections.
More Related Videos
Related Concept Videos
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Development of Antibiotic Resistance
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
Antibiotic Selection
Antimicrobial Effectiveness

